UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Effectiveness of 23-valent pneumococcal polysaccharide vaccine in adults aged 60 years and over in the Region of Madrid, Spain, 2008–2011

Euro surveillance : bulletin européen sur les maladies transmissibles, 2014-10, Vol.19 (40), p.1

2014

Volltextzugriff (PDF)

SARS-CoV-2 variants, a still unfinished story

Vacunas, 2021-09, Vol.22 (3), p.173-179

2021

Volltextzugriff (PDF)

Incidence and Severity of COVID-19 in HIV-Positive Persons Receiving Antiretroviral Therapy : A Cohort Study

Annals of internal medicine, 2020-10, Vol.173 (7), p.536-541

2020

Volltextzugriff (PDF)

Seroprevalence of measles and rubella virus antibodies in the population of the Community of Madrid, 2008–2009

Journal of infection and public health, 2015-09, Vol.8 (5), p.432-440

2015

Volltextzugriff (PDF)

Systemic and extrapulmonary manifestations of COVID-19

Medicine - programa de formación médica continuada acreditado, 2022-05, Vol.13 (55), p.3235

2022

Volltextzugriff (PDF)

Risk factors and clinical significance of invasive infections caused by levofloxacin-resistant Streptococcus pneumoniae

Infection, 2013-10, Vol.41 (5), p.935-939

2013

Volltextzugriff (PDF)

Dual treatment with atazanavir–ritonavir plus lamivudine versus triple treatment with atazanavir–ritonavir plus two nucleos(t)ides in virologically stable patients with HIV-1 (SALT): 48 week results from a randomised, open-label, non-inferiority trial

The Lancet infectious diseases, 2015-07, Vol.15 (7), p.775-784

2015

Volltextzugriff (PDF)

Protocolo de diagnóstico diferencial de las faringoamigdalitis

Medicine - programa de formación médica continuada acreditado, 2010-06, Vol.10 (58), p.4015-4018

Sanz Moreno, J

2010

Volltextzugriff (PDF)

Evolution of the serotypes causing invasive pneumococcal disease along 2008-2022 in a Level 2 Public Hospital of the Madrid Region, in relation to their inclusion in different conjugate vaccines

Revista española de quimioterapia, 2023-12, Vol.36 (6), p.597-603

2023

Volltextzugriff (PDF)

Respuesta a «Cómo limitar los sesgos en estudios cuasiexperimentales

Enfermedades infecciosas y microbiología clínica, 2020-01, Vol.38 (1), p.46-47

2020

Volltextzugriff (PDF)

Neurocognitive safety after 96 weeks on dual therapy with atazanavir/ritonavir plus lamivudine: results of the neurocognitive substudy of the SALT randomized clinical trial

Journal of antimicrobial chemotherapy, 2018-09, Vol.73 (9), p.2444-2451

2018

Volltextzugriff (PDF)

Approach to COVID-19 pandemic management in Madrid. Chronic of a year

Revista española de quimioterapia, 2021-09, Vol.34 Suppl 1 (Suppl 1), p.76-80

2021

Volltextzugriff (PDF)

Incidence of hepatocellular carcinoma in HIV-infected patients with cirrhosis: a prospective study

Journal of acquired immune deficiency syndromes (1999), 2014-01, Vol.65 (1), p.82-86

2014

Volltextzugriff (PDF)

Q fever in pregnancy: case report after a 2-year follow-up

The Journal of infection, 1998-07, Vol.37 (1), p.79-81

1998

Volltextzugriff (PDF)

Unboosted atazanavir-based therapy maintains control of HIV type-1 replication as effectively as a ritonavir-boosted regimen

Antiviral therapy, 2010-01, Vol.15 (7), p.993-1002

2010

Volltextzugriff (PDF)

Simplification to dual therapy (atazanavir/ritonavir + lamivudine) versus standard triple therapy [atazanavir/ritonavir + two nucleos(t)ides] in virologically stable patients on antiretroviral therapy: 96 week results from an open-label, non-inferiority, randomized clinical trial (SALT study)

Journal of antimicrobial chemotherapy, 2017-01, Vol.72 (1), p.246-253

2017

Volltextzugriff (PDF)

Detection of secondary mumps vaccine failure by means of avidity testing for specific immunoglobulin G

Vaccine, 2005-09, Vol.23 (41), p.4921-4925

2005

Volltextzugriff (PDF)

Systemic and extrapulmonary manifestations of COVID-19

Medicine - programa de formación médica continuada acreditado, 2022-05, Vol.13 (55), p.3235-3245

2022

Volltextzugriff (PDF)

Manifestaciones sistémicas y extrapulmonares en la COVID-19

Medicine - programa de formación médica continuada acreditado, 2022-05, Vol.13 (55), p.3235-3245

2022

Volltextzugriff (PDF)

Neumonías bacterianas no neumocócicas (I). Infecciones por Legionella, fiebre Q y otras

Medicine - programa de formación médica continuada acreditado, 2022-05, Vol.13 (55), p.3203-3214

2022

Volltextzugriff (PDF)

Medicine

Medicine - programa de formación médica continuada acreditado, 2010-06, Vol.10 (58), p.4015-4018

Sanz Moreno, J

2010

Volltextzugriff (PDF)

Protocolo de diagnóstico diferencial de las faringoamigdalitis

Medicine - programa de formación médica continuada acreditado, 2010-06, Vol.10 (58), p.4015-4018

Sanz Moreno, J.

2010

Volltextzugriff (PDF)

Fosamprenavir (GW433908)/ritonavir in HIV-infected patients: efficacy and safety results from the Spanish Expanded Access Program

Enfermedades infecciosas y microbiología clínica, 2009-01, Vol.27 (1), p.28-32

2009

Volltextzugriff (PDF)

Increased Indoleamine-2,3-Dioxygenase Activity Is Associated With Poor Clinical Outcome in Adults Hospitalized With Influenza in the INSIGHT FLU003Plus Study

Open forum infectious diseases, 2018-01, Vol.5 (1), p.ofx228

2018

Volltextzugriff (PDF)

Parotiditis en un área urbana de la Comunidad de Madrid. Estado vacunal, diagnóstico y medidas de intervención

Atención primaria, 2001-01, Vol.28 (1), p.10-16

2001

Volltextzugriff (PDF)

1 – 25 von 188

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(171)
Mit Volltextzugriff
(129)

Publikationsform

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Effectiveness of 23-valent pneumococcal polysaccharide vaccine in adults aged 60 years and over in the Region of Madrid, Spain, 2008–2011

SARS-CoV-2 variants, a still unfinished story

Incidence and Severity of COVID-19 in HIV-Positive Persons Receiving Antiretroviral Therapy : A Cohort Study

Seroprevalence of measles and rubella virus antibodies in the population of the Community of Madrid, 2008–2009

Systemic and extrapulmonary manifestations of COVID-19

Risk factors and clinical significance of invasive infections caused by levofloxacin-resistant Streptococcus pneumoniae

Dual treatment with atazanavir–ritonavir plus lamivudine versus triple treatment with atazanavir–ritonavir plus two nucleos(t)ides in virologically stable patients with HIV-1 (SALT): 48 week results from a randomised, open-label, non-inferiority trial

Protocolo de diagnóstico diferencial de las faringoamigdalitis

Evolution of the serotypes causing invasive pneumococcal disease along 2008-2022 in a Level 2 Public Hospital of the Madrid Region, in relation to their inclusion in different conjugate vaccines

Respuesta a «Cómo limitar los sesgos en estudios cuasiexperimentales

Neurocognitive safety after 96 weeks on dual therapy with atazanavir/ritonavir plus lamivudine: results of the neurocognitive substudy of the SALT randomized clinical trial

Approach to COVID-19 pandemic management in Madrid. Chronic of a year

Incidence of hepatocellular carcinoma in HIV-infected patients with cirrhosis: a prospective study

Q fever in pregnancy: case report after a 2-year follow-up

Unboosted atazanavir-based therapy maintains control of HIV type-1 replication as effectively as a ritonavir-boosted regimen

Simplification to dual therapy (atazanavir/ritonavir + lamivudine) versus standard triple therapy [atazanavir/ritonavir + two nucleos(t)ides] in virologically stable patients on antiretroviral therapy: 96 week results from an open-label, non-inferiority, randomized clinical trial (SALT study)

Detection of secondary mumps vaccine failure by means of avidity testing for specific immunoglobulin G

Systemic and extrapulmonary manifestations of COVID-19

Manifestaciones sistémicas y extrapulmonares en la COVID-19

Neumonías bacterianas no neumocócicas (I). Infecciones por Legionella, fiebre Q y otras

Medicine

Protocolo de diagnóstico diferencial de las faringoamigdalitis

Fosamprenavir (GW433908)/ritonavir in HIV-infected patients: efficacy and safety results from the Spanish Expanded Access Program

Increased Indoleamine-2,3-Dioxygenase Activity Is Associated With Poor Clinical Outcome in Adults Hospitalized With Influenza in the INSIGHT FLU003Plus Study

Parotiditis en un área urbana de la Comunidad de Madrid. Estado vacunal, diagnóstico y medidas de intervención

Suchergebnisse filtern